PERC: Pediatric Epilepsies & Rare CNS Gene Editing Platform
The team will establish a portfolio of genetic medicine platforms targeting difficult-to-treat CNS disorders, including childhood epilepsies, which represent areas of profound unmet need in pediatric populations. In parallel, the team will pioneer a novel deployment model for genetic therapies designed to enable sustainable delivery of these treatments and future platform-derived therapies at scale.